Literature DB >> 23739986

The neuropsychiatric translational revolution: still very early and still very challenging.

Lara Braff1, David L Braff.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23739986      PMCID： PMC4018228          DOI： 10.1001/jamapsychiatry.2013.2184

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  10 in total

1.  Psychiatry in the genomics era.

Authors:  Thomas R Insel; Francis S Collins
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

2.  Clinically responsible genetic testing in neuropsychiatric patients: a bridge too far and too soon.

Authors:  David L Braff; Robert Freedman
Journal:  Am J Psychiatry       Date:  2008-08       Impact factor: 18.112

3.  From fatty streak to fatty liver: 33 years of joint publications in the JCI.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Reengineering translational science: the time is right.

Authors:  Francis S Collins
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

5.  Human genetics. Genetic influences on disease remain hidden.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2012-11-23       Impact factor: 47.728

6.  Next-generation treatments for mental disorders.

Authors:  Thomas R Insel
Journal:  Sci Transl Med       Date:  2012-10-10       Impact factor: 17.956

7.  The best of times, the worst of times for psychiatric disease.

Authors:  Maria Karayiorgou; Jonathan Flint; Joseph A Gogos; Robert C Malenka
Journal:  Nat Neurosci       Date:  2012-05-25       Impact factor: 24.884

8.  Are we studying and treating schizophrenia correctly?

Authors:  Neal R Swerdlow
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

9.  Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia.

Authors:  Melissa Fisher; Christine Holland; Michael M Merzenich; Sophia Vinogradov
Journal:  Am J Psychiatry       Date:  2009-05-15       Impact factor: 18.112

10.  Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia.

Authors:  Joshua L Roffman; J Steven Lamberti; Eric Achtyes; Eric A Macklin; Gail C Galendez; Lisa H Raeke; Noah J Silverstein; Jordan W Smoller; Michele Hill; Donald C Goff
Journal:  JAMA Psychiatry       Date:  2013-05       Impact factor: 21.596
  10 in total
  7 in total

Review 1.  Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.

Authors:  M D Bauman; C M Schumann
Journal:  Exp Neurol       Date:  2017-08-01       Impact factor: 5.330

Review 2.  Endophenotypes, Epigenetics, Polygenicity and More: Irv Gottesman's Dynamic Legacy.

Authors:  David L Braff; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2016-11-21       Impact factor: 9.306

3.  NIMH neuropsychiatric genomics: crucial foundational accomplishments and the extensive challenges that remain.

Authors:  D L Braff
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

4.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

5.  Lack of use in the literature from the last 20 years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11.

Authors:  David L Braff; James Ryan; Anthony J Rissling; William T Carpenter
Journal:  Schizophr Bull       Date:  2013-05-14       Impact factor: 9.306

6.  Behavioral Phenotyping of Juvenile Long-Evans and Sprague-Dawley Rats: Implications for Preclinical Models of Autism Spectrum Disorders.

Authors:  Katherine M Ku; Ruth K Weir; Jill L Silverman; Robert F Berman; Melissa D Bauman
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

Review 7.  The translational study of apathy-an ecological approach.

Authors:  Flurin Cathomas; Matthias N Hartmann; Erich Seifritz; Christopher R Pryce; Stefan Kaiser
Journal:  Front Behav Neurosci       Date:  2015-09-09       Impact factor: 3.558
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.